Jim Simons
ZVRA icon

Jim Simons’s Zevra Therapeutics ZVRA Stock Holding History

Jim Simons’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-112,800
Closed -$553K – 3952
2024
Q2 		$553K Sell
112,800
-42,600
-27% -$202K ﹤0.01% 2655
2024
Q1 		$901K Sell
155,400
-15,100
-9% -$92.8K ﹤0.01% 2546
2023
Q4 		$1.12M Buy
170,500
+37,800
+28% +$177K ﹤0.01% 2336
2023
Q3 		$640K Buy
132,700
+800
+0.6% +$3.99K ﹤0.01% 2599
2023
Q2 		$673K Buy
131,900
+28,100
+27% +$151K ﹤0.01% 2712
2023
Q1 		$571K Buy
103,800
+22,800
+28% +$121K ﹤0.01% 2813
2022
Q4 		$372K Buy
81,000
+9,100
+13% +$46.2K ﹤0.01% 3121
2022
Q3 		$449K Sell
71,900
-31,494
-30% -$178K ﹤0.01% 2987
2022
Q2 		$461K Sell
103,394
-77,397
-43% -$353K ﹤0.01% 3208
2022
Q1 		$909K Buy
180,791
+162,291
+877% +$1.03M ﹤0.01% 2793
2021
Q4 		$161K Sell
18,500
-147,100
-89% -$1.31M ﹤0.01% 3587
2021
Q3 		$1.54M Buy
+165,600
New +$1.67M ﹤0.01% 2288
2020
Q2 		– Sell
-10,662
Closed -$38K – 3818
2020
Q1 		$38K Buy
+10,662
New +$59K ﹤0.01% 3344
2018
Q4 		– Sell
-6,488
Closed -$498K – 3663
2018
Q3 		$498K Sell
6,488
-4,875
-43% -$381K ﹤0.01% 2849
2018
Q2 		$1.18M Buy
11,363
+5,713
+101% +$558K ﹤0.01% 2530
2018
Q1 		$714K Buy
+5,650
New +$546K ﹤0.01% 2793

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jim Simons's ZVRA Position: Q3 2024 in Review

Jim Simons sold out of Zevra Therapeutics (ZVRA) in Q3 2024, closing a stake of 112,800 shares — an estimated $553K sold.

Jim Simons first reported a position in ZVRA in Q1 2018 and held it in 16 quarters. The position peaked at $1.54M in Q3 2021. 108 funds tracked by Wall St. Rank hold ZVRA as of Q3 2024.

  • Jim Simons reported no remaining Zevra Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Jim Simons sold 112,800 Zevra Therapeutics shares in Q3 2024, an estimated $553K.
  • Jim Simons first reported a position in Zevra Therapeutics in Q1 2018 and held it in 16 quarters.
  • Jim Simons's Zevra Therapeutics position peaked at $1.54M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2024.

Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.